Contraceptive Drugs Market Research Report- Global Forecast to 2023

1. Market Research Future Contraceptive Drugs Market by Value, Revenue, Segments, Mega trends, Prominent Players and Outlook to 2023 Contraceptive Drugs Market - Scenario The global contraceptive drugs market is showing the moderate growth; mainly due to increase to avoid unwanted pregnancies and their complication. Moreover, increasing incidence of STIs and the rapid increase in population. Most of the countries around the world are facing the issues of unintended pregnancy by adolescents, especially in developing region. According to report published by World Health Organization (WHO) in 2018, around 21 million girls aged 15 to 19 years and 2 million girls aged under 15 years become pregnant every years in developing regions. Moreover, around 16 million girls of aged 15 to 19 years and 2.5 million girls of aged 16 years give birth each year in developing regions. Request Sample Copy at https://www.marketresearchfuture.com/sample_request/1276 Companies are showing much interest toward the contraceptive drugs market, as they feel there are huge opportunities and gaps between the market demand and supply of effective drugs. Thus, companies are investing more into research and development activities to introduce better drugs in the market. The development has been made by Pfizer in September 2015, when they announced that Sayana Press (medroxyprogesterone acetate), is now available to women in the United Kingdom (UK) for administration by self-injection, after getting the approval from UK Medicines and Healthcare Products Regulatory Agency (MHRA). Players Covered: Merck & Co., Inc (U.S.), Pfizer Inc (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Bayer AG (Germany), Allergan plc. (Ireland), Janssen Global Services llc. (U.S.), Mankind Pharma Ltd. (India), Piramal Enterprises Ltd (India), Reckitt Benckiser Plc (U.K), Church & Dwight (U.S.), The Female Health Company (U.S.), Mayer Laboratories (U.S.), Cooper Surgical (U.S.) are some of the leading players at the cutting edge of the competition in the market of Contraceptive drugs, globally. Regional Wise Analysis: The market of contraceptive drugs is much higher in the Americas region owing to increasing awareness among the people and high incidence rates of abortion. According to the report published by Centers for Disease Control and Prevention in 2015, around 229,715 babies were born from women aged between 15 to 19 years. Europe is also considering the huge market for contraceptive drugs players, owing to the increasing government support and awareness about healthcare industries, and well-

2. Market Research Future developed technology. Moreover, companies from these regions are more into export to the developing region which increase the market share around the globe. Asia Pacific and the Middle East and Africa region are considering the big market. Whereas country like India and china of Asia Pacific region are considering fastest growing region due to the high rate of incidence of teen pregnancy. According to WHO, adolescent birth rates is 45 births per 1000 women in South-Eastern Asia and 7 births per 1000 women in Eastern Asia. Additionally, they are open to adopt new treatment option from a developed country, this gap between the developed and developing countries will present significant growth opportunities for the contraceptive drugs market players in the coming years. Browse Complete Report at https://www.marketresearchfuture.com/reports/contraceptive- drugs-market-1276 About US: Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact Us: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India Phone: +1 646 845 9312 Email: sales@marketresearchfuture.com